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Background: Post-traumatic stress disorder (PTSD) is an anxious disorder associated with low levels of corticosterone
and enhanced negative feedback of the hypothalamic–pituitary–adrenal (HPA) axis. Previous studies showed that
the amygdala not only has an excitatory effect on the HPA axis but also plays a key role in fear-related behaviors.
Coticosterone exert actions through binding to the mineralocorticoid (MR) and glucocorticoid receptor (GR), which are
abundant in the amygdala. In our previous study, down-regulation of MR and GR in the hippocampus of PTSD rats was
found. But the roles of MR and GR in the amygdala of PTSD rats is incompletely understood.
Results: wistar rats were divided into 1 d, 7 d, 14 d groups after single prolonged stress (SPS) and control group. SPS is
a reliable animal model of PTSD. Open field test (OF) and elevated plus maze tests (EPM) were performed to examine
fear-related behaviors. Morphological changes of the ultrastructure of the amygdala neurons were assessed by
transmission electron microscopy (TEM). Dual-immunofluorescence histochemistry was used to determined subcellular
distribution and colocalization of MR- and GR-ir. Protein and mRNA of MR and GR was examined by western blotting
and RT-PCR. OF and EPM showed enhanced fear in SPS rats. Abnormal neuronal morphology was discovered in the
amygdala of SPS rats. The expression of MR- and GR-ir intensity, mRNA and protein within the amygdala decreased
after SPS at 1 day, and then gradually recovered by 14 days, although the degree of decrease and recovery were
different amongst techniques. We found no change in the MR/GR ratio at 3 levels of the amygdala. But more
cytoplasmic distribution and decreased colocalization of MR- and GR-ir were observed in the amygdala after
7 days of SPS.
Conclusion: These data suggest that change of MR and GR in the amygdala are involved in the mechanisms of
fear in PTSD.
Keywords: Mineralocorticoid receptor, Glucocorticoid receptor, Amygdala, Post-tramumatic stress disorder, Single
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Post-traumatic stress disorder (PTSD) is an anxiety dis-
order that develops after exposure to a life-threatening
traumatic experience, and is characterized by intrusive
memories, a hyper-arousal state and avoidance of stimuli
associated with the trauma [1]. PTSD is also characterized
by changes in the neuroendocrine system including abnor-
mal blood corticosteroid concentration and enhanced
negative feedback of the hypothalamic–pituitary–adrenal* Correspondence: shiyuxiu@163.com
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unless otherwise stated.(HPA) axis [2,3]. Corticosteroids inhibit the HPA axis via
2 types of corticosteroid receptors: mineralocorticoid re-
ceptors (MR) and glucocorticoid receptor (GR) [3]. With-
out corticosterone, unbound MR and GR are believed to
be primarily localized in the cytoplasm, but can translo-
cate to the nucleus after binding to the hormone ligand.
Both receptors show different affinity for corticosteroids;
MR has a higher affinity for corticosteroids than the GR
[4,5]. At basal levels of corticosterone, MR is believed to
be predominant in the maintenance of homeostasis,
whereas GR becomes activated when corticosteroid levels
increase after stress [3].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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for mimicking the pathophysiology and behavioral char-
acteristics of PTSD. Among these animal models of
PTSD, a single prolonged stress (SPS) model was firstly
proposed by Liberzon et al. [6], which consists of 3
stages: 2 h restraint, 20 min forced swim in 37°C water,
and exposure to ether anesthesia. SPS rats express en-
hanced negative feedback of the HPA axis and low levels
of corticostone in plasma, which resemble neuroendo-
crinology changes in PTSD [6].
The amygdala is one of the key regions in the limbic
system of the brain and has been thought to have an
important role in the emotional memory such as fear.
Amygdala has three distinct subgroups: central nucleus,
corticomedial nucleus, and basolateral nucleus [7]. The
basolateral nucleus is the largest among these three and
has been strongly implicated as key sites for stress and
fear/anxiety functions [8,9]. Magnetic resource image
(MRI) studies reveal significant amygdala volume reduc-
tion in adult patients with PTSD [10,11]. Our previous
study noted a higher apoptosis rate in the amygdala with
TUNEL-staining and double-labeled flow cytometry
methods. Changed apoptosis-related protein (Bcl-2 and
Bax) were also found in the amygdala of the SPS rats
[12]. These studies suggest abnormal amygdala structure
and function is involved in PTSD. On the other hand,
neuroendocrine studies from Feldman suggest that the
amygdala has an excitatory effect on the HPA axis, as
noted by increased corticosterone levels after amygdala
stimulation, as well as inhibition of the HPA axis re-
sponses to stress in rats with amygdala lesions [13,14].
MR and GR have a high density of expression in the
amygdala [4]. It has been reported that adding of corti-
costeroids to the amygdala enhanced anxiety-like behav-
ior [15]. Blockade of both GR and MR produced an
increase in startle response [16]. GR and MR antagonist
increased the percentage of time the rats spent on open
arms, and increased the amount of entries into these
open arms in the Elevated Plus-Maze test [17]. These
findings suggest that effects of both receptors have been
implicated in the fear-enhancing effects of glucocor-
ticoids [18]. The bulk of studies on both receptors have
focused on hippocampal neurons, but no work has shed
light on their function in the amygdala related to PTSD.
In our previous study, down-regulation of MR and GR
in the hippocampus of PTSD rats was found [19]. But
the roles of MR and GR in the amygdala of PTSD rats is
incompletely understood.
In the present study, we aimed to address the effects
of SPS on fear using behavioral tests, and determining
morphological changes of the amygdala neurons. To ex-
plore the expression of MR and GR, we determined the
levels of protein and mRNA using dual-fluorescence
histochemistry, western blotting and RT-PCR.Methods
Animal model preparation and grouping
A total of 60 male Wistar rats (220–250 g) were ran-
domly divided into 4 groups (15 rats per group): a con-
trol group, SPS groups examined on day 1 (1 day), day 7
(7 days) and day 14 (14 days). The control rats remained
in their home cages with no handling for 14 days and
were killed at the same time as the SPS groups. The SPS
rats underwent the SPS procedure on the first day. The
SPS procedure was carried out according to the fol-
lowing protocol [6]: a 2 h immobilization (compression
with plastic bags), a 20 min forced swim (25°C), a
15 min rest, followed by ether anesthesia (until loss of
consciousness). After SPS, the rats were fed routinely.
The study was approved by the ethics committee of
China Medical University. Experiments were carried out
in accordance with the Guidelines laid down by the NIH
in the US regarding the care and use of animals for ex-
perimental procedures.
Behavioral test
All rats of each group underwent the behavioral test (the
open field (OF) test and elevated plus maze (EPM) test)
at two hours before being killed. The EPM test was car-
ried out at one hour after OF test.
Open field (OF) test
The open-field test was used to study anxiety/fear-re-
lated behavior. The apparatus was surrounded by black
walls 40 cm in height, and the floor (100 cm × 100 cm)
was divided into 25 squares (20 cm × 20 cm each). Du-
ring the experiment, each rat was put in the center of
the open field, and behavior was recorded for 5 min by
an automatic analyzing system. Time of centre cross, the
number of centre cross and total cross, and the number
of rearing were recorded. The apparatus was cleaned
with water using a wet sponge and a paper towel before
the introduction of each rat.
Elevated Plus Maze (EPM) test
EPM has been well validated in detecting responses to ex-
ternal stressful stimuli. The EPM apparatus consists of a
plus-shaped maze elevated above the floor with 2 oppo-
sitely positioned closed arms (50 cm× 10 cm), 2 oppos-
itely positioned open arms (50 cm× 10 cm), and a center
area (10 × 10 cm). At the beginning, rats were placed in
the central area of the maze, facing an enclosed arm. Be-
havior was recorded with a video camera during the initial
5 min. The number of entries into open arms, into closed
arms and the time spent in the open arms, in the closed
arms were measured. The percentage of open arm entries
(number of entries into the open arm/total number of en-
tries in both arms), and the percentage of time in the open
arms (time in the open arms /the time in both arms) were
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tage (%) of open arm entries and the percentage (%) of
time spent on the open arms. The number of closed arm
entries is considered locomotor measures.
Transmission electron microscopy (TEM)
Rats (n = 3) of each group were perfused through the heart
with a mixture of 2% paraformaldehyde and 2.5% glutaral-
dehyde in phosphate buffer. The brains were removed and
fixed in the same fixative solution for one night. The amyg-
dala was cut into 1 mm3 blocks. The blocks were post-fixed
in 1% osmium tetroxide for 2 h at 4°C. After dehydration in
graded concentrations of ethanol, the specimens were
treated with propylene oxide and embedded in Epon 812
for 2 days at 65°C. Semi-thin sections stained with 1% tolui-
dine blue were examined using a light microscope, and suit-
able regions were carefully selected for trimming of the
blocks. Ultra-thin sections stained with uranyl acetate and
lead citrate were examined using a transmission electron
microscope (JEM-1200EX; Jeol, Tokyo, Japan).
Brain tissue preparation and Dual-labeling
immunofluorescence of MR and GR in the amygdala
Rats of each group (n = 4) were infused with 300 ml of
0.01 M PBS (pH 7.4) including 4% paraformaldehyde. The
whole brains were rapidly removed into the same fixative
for 24 h at 4°C. The brains were immersed in 30% sucrose
in 0.1 M PB for 3 days for cryosections. The brain tissue
was cut into slices of 15 um thickness using a cryostat
(Leica CM 3050, Germany). The sections were washed 3
times (5 min each) with 0.01 M PBS, and then treated with
2% BSA in PBS for 2 h at RT for blocking nonspecific reac-
tions. The sections were treated with mouse monoclonal
anti-MR antibody (diluted to 1:200; Santa Cruz; CA, USA)
and rabbit polyclonal anti-GR antibody (diluted to 1:500;
Santa Cruz; CA, USA) in TBS solution for 24 h at 4°C. The
sections were washed 3 times with TBS, and then incubated
with Alexa Fluor 488 labeled anti-rabbit IgG (1:1,000; Mo-
lecular Probes, USA) and Alexa Fluor 546 labeled anti-
mouse IgG (1:1,000; Molecular Probes, USA) in 2% BSA-
PBS for 2 h at RT. After being washed 3 times with PBS,
the sections were observed under a confocal laser-scanning
microscope (TCS SP2; Leica, Wetzlar, Germany).
Six slides were randomly selected from each rat. For each
slide, 5 randomly selected visual fields in the amygdala
were chosen (×40 magnification). We recorded the optical
density (OD) of positive cells in each field to evaluate the
average OD. The OD of MR and GR-immunopositive cells
were analyzed using a Meta Morph/DPIO/BX41 mor-
phology image analysis system.
Western blotting analysis of MR and GR
Rats (n = 4 per group) were decapitated, and the brains
were immediately removed and quick frozen in liquidnitrogen and stored at −80°C. The amygdala was then dis-
sected from brain tissue according to the atlas [20] using a
stereomicroscope. The amygdala of each rat was homoge-
nized with a buffer containing 200 mM TBS, 4% SDS, 20%
glycerol, and 10% 2-mercaptoethanol, and were denatured
by boiling for 5 min. Samples (50 μg/lane) were loaded on
a 7.5% SDS-polyacrylamide gel, and electro-blotted onto a
PVDF membrane (Millipore Corp., Bedford, MA) from
the gel by a semi-dry blotting apparatus (Bio-Rad Labora-
tories, Inc, Hercules, CA). The PVDF membrane was
treated with 1.5% skim milk, 0.05% Tween-20 in TBS
(TBST) at 4°C overnight, and then incubated with 1:200
mouse monoclonal antibody against MR (Santa Cruz,
USA) or 1:500 rabbit polyclonal antibody against GR
(Santa Cruz, USA) at 4°C for 24 h. After being washed 3
times with TBST, the blots were incubated with a second
antibody (anti-mouse or anti-rabbit IgG-HRP from Santa
Cruz; 1:1,000) for 2 h at room temperature. After in-
cubation, blots were washed 3 times with TBST, and then
were visualized using enhanced chemiluminescence (ECL;
Amersham Pharmacia Biotech). The same blots were in-
cubated with antibodies against β-actin (Abcam, British;
1:1,000) as positive control. The protein levels of MR and
GR were evaluated by calculating the OD ratio of MR/β-
actin and GR/β-actin. The OD of MR, GR, and β-actin
were analyzed on the Gel Image Analysis System (Tanon
2500R, Shanghai, China). The procedures were repeated 6
times to obtain the average value.
Total RNA extraction and RT-PCR of MR and GR mRNA
After decapitation, the amygdala from each group (n = 4)
was dissected and removed from the brain. Total RNA was
extracted using TRIzol (Invitrogen, Japan) according to the
manufacturer’s instructions. 1 μg of total RNA was reverse
transcribed into cDNA with a RNA PCR Kit (AM Ver.3.0,
TaKaRa bio, Otsu, Japan). The primers were synthesized by
Shenggong Biotech Limited Company (Shanghai, China).
The sequences of MR primers were: 5′-AGA AGA TGC
ATC AGT CTGCC-3′ (upper) and 5′-GTG ATG ATC
TCC ACC AGC AT-3′ (lower). The sequences of GR
primers were: 5′-ATC CCA CAG ACC AAA GCA CCT
T-3′ (upper) and 5′-TCC AGT TTT CAG AAC CAA
CAGG-3′ (lower). The sequences of β-actin primers were:
5′-GTC ACC CAC ACT GTG CCC ATC-3′ (upper) and
5′-ACA GAG TAC TTG CGC TCA GGA-3′ (lower).
PCR was performed using a thermal cycler (XP cycler,
Bioer, Japan) consisting of denaturation at 94°C for 5 min,
32 additional cycles at 94°C for 50 s, and then 45 s of pri-
mer annealing at 58°C (for MR), 56.5°C (for GR), and 53°C
(for β-actin), followed by a final extension at 72°C for
8 min. The lengths of amplified fragments of MR, GR, and
β-actin were 380 bp, 540 bp, and 542 bp, respectively. The
PCR products were separated after electrophoresis on 1%
(w/v) agarose gel, and the optical density of each band was
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Shanghai, China). The levels of MR and GR mRNA were
determined by calculating the optical density ratio of MR/
β-actin and GR/β-actin.
Analyzing the percentage of MR- and GR-immunoreactive
(ir) cells in the amygdala
Confocal laser-scanning microscopic images (100 μm×
100 μm) from every fifth section in the amygdala were
randomly captured using a computer. For each image,
approximately 50 cells were counted. The number of
MR-ir cells, GR-ir cells, and the cells colocalized with
MR- and GR-ir were counted. The percentage of MR-ir
cells that showed GR-ir, and that of GR-ir cells that
showed MR-ir, were calculated.
Statistics
The results were expressed as mean ± S.E.M. The diffe-
rences between normal control group and SPS groups
were analyzed by one-way analysis of variance (ANOVA)
followed by Tukey’s post-hoc test using SPSS 13.0 soft-
ware. A level of P < 0.05 was considered to be statisti-




Effects of SPS on performance in the open field (OF) tests
were shown at Table 1. Rats showed a significant reduc-
tion in time spent in the central area (*P < 0.05) as well as
a reduction in the number of central squares crossed at
1 day, 7 days and 14 days after SPS exposure in compari-
son with control group. In addition, rats presented a sig-
nificant reduction in the number of rearings at 1 day,
7 days and 14 days after SPS exposure (*P < 0.05). We did
not found the significant difference in the number of total
cross among these experimental groups.
In the Elevated Plus Maze (EPM) Test (Table 2), the
percentage of time in the open arms (time in the open
arms /the time in both arms) and the percentage of open
arm entries (number of entries into the open arm/total
number of entries in both arms) were calculated. Rats
showed a significant reduction in the percentage of time
spent in the open arm (*P < 0.05) and percentage of the
number of entries into open arms (*P < 0.05) at 1 day,Table 1 Open-field test
Time in centre (s) Number of center c
SPS −1 day 12.34 ± 0.54 40.10 ± 3.90
SPS 1 day 7.76 ± 2.35* 32.65 ± 4.87
SPS 7 days 5.13 ± 0.91* 31.35 ± 3.43*
SPS 14 days 4.25 ± 1.57* 30.47 ± 2.45*
Statistical analysis was carried out by ANOVA test (*P < 0.05 compared with control7 day and 14 day after SPS exposure in comparison with
control group. There were no difference in the number
of close arm entries among control group and SPS
groups. These results indicated SPS induced increased
fear/anxious-related behaviors.
TEM analysis of the morphological changes in the
amygdala cells of SPS rats
As shown in Figure 1, the amygdala cells in the control
rats exhibited normal morphology (Figure 1A). Some cells
in the amygdala of SPS 7 day rats exhibited abnormal
morphology including chromatin condensation (shown
with arrow, Figure 1B) as well as nucleus fragmentation
(shown with asterisk, Figure 1B). Also, some cell orga-
nelles showed abnormal morphology, such as the mito-
chondria expressed swelling, vacuolation (shown with
arrow head, Figure 1C). These change were also found in
the amygdalar cells of SPS 1 day and 7 day rats (data not
shown). These changes in cell morphology and cell organ-
elles suggested that SPS induced damage of the amygdala
cells.
Coexpression of MR- and GR-ir in the amygdala
Double immunofluorescent staining clearly showed that
MR- and GR-ir was observed in the cytoplasm and
nucleus of the amygdala cells (Figure 2A), but MR-ir
(Figure 2A-1) showed more cytoplasmic distribution than
GR-ir (Figure 2A-2) in the control rats. Merged yellow
fluorescence confirmed the colocalization of MR- and
GR-ir in the nuclear, but not cytoplasmic, compartment of
the amygdala cells (Figure 2A-3). The effect of SPS on the
distribution and intensity of MR- and GR-ir were exa-
mined. At 1 day after SPS (Figure 2B), the intensity of
MR- (Figure 2B-1) and GR-ir (Figure 2B-2) within the
amygdala significantly decreased in comparison with
the control group. At 7 days (Figure 2C) and 14 days
(Figure 2D) after SPS, MR- and GR-ir showed no signifi-
cant difference in intensity in comparison with control
group. But, SPS induced more cytoplasmic distribution of
MR- ir and GR-ir in the SPS 7 days and 14 days.
We counted the number of colocalized MR- and GR-ir
cells, and found that 93.5 ± 2.3% MR-ir cells and 92.8 ±
3.4% GR-ir cells expressed GR- and MR-ir in the amygdala
of the control group, respectively. In the SPS 1 day rats,
34.3 ± 2.4% MR-ir cells expressed GR-ir and 76.5 ± 4.1%ross Number of total cross Number of rearing
86.58 ± 23.43 18.10 ± 0.89
75.65 ± 14.30 9.37 ± 1.65*
78.69 ± 17.45 6.21 ± 0.79*
79.23 ± 9.58 7.47 ± 1.52*
group).
Table 2 EPM test
Time spent in open arm (%) Number of open arm entries (%) Number of close arm entries
SPS −1 day 18.34 ± 3.21 37.57 ± 2.37 13.51 ± 6.21
SPS 1 day 13.93 ± 2.57 25.64 ± 1.94* 9.46 ± 4.46
SPS 7 days 12.52 ± 2.15* 20.37 ± 2.18* 12.13 ± 3.85
SPS 14 days 11.28 ± 1.09* 21.55 ± 2.35* 10.43 ± 2.38
Statistical analysis was carried out by ANOVA test (*P < 0.05 compared with control group).
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2.9% MR-ir cells expressed GR-ir and 85.2 ± 3.2% GR-ir
cells expressed MR-ir, respectively. In the SPS 14 day rats,
MR-ir cells showed 91.4 ± 2.45% GR-ir and 69.3 ± 2.7%
GR-ir cells showed MR-ir, respectively (Table 3).
Western blotting of MR and GR in the amygdala
The protein signals for MR, GR, and β-actin appeared on
Western blot at 106 KD, 87 KD, and 42 KD, respectively.
Changes in MR and GR expression within the amygdala
region between control and SPS rats are presented inFigure 1 TEM images of the amygdala in SPS rats. TEM images of the a
organelles such as mitochondria, endoplasmic reticulum, and ribosomes. T
nucleolus is clear. B: Chromatin condensation (shown with arrow) and nuc
of SPS 7 day rats. C: The mitochondria showed swelling, vacuolation and lo
7 day rats. Scale bar, 300 nm.Figure 3. The band mean density of the control group was
set as 100%. Data were expressed as normalized optical
density. β-actin protein level was used as the internal con-
trol at each time point. MR and GR expression were sig-
nificantly decreased in SPS 1 day, 7 days and 14 days rats
in comparison with control rats (Figure 3).
RT-PCR of MR mRNA and GR mRNA
The levels of MR and GR mRNA were normalized with
β-actin mRNA levels. Similar to the Western blot, the
mRNA levels of MR and GR in the SPS rats weremygdala. A: Normal control amygdala neuron, displaying abundant
he nucleus is large and round, density of chromatin is uniform, and
leolus disappearance (shown with star) is shown in the amygdala cells
ss of crest (shown with arrowhead) in cells of the amygdala from SPS
Figure 2 (See legend on next page.)
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Figure 2 Effects of SPS on the intensity and localization of MR- and GR-ir in the amygdala. Dual-immunofluorescent images for the MR- and
GR-ir in the amygdala. Images of MR-ir (red; left panel), GR-ir (green; middle panel), and colocalization of MR- and GR-ir (yellow; right panel) in the control
group (A), 1 day SPS (B), 7 days SPS (C), and 14 days SPS (D). E shows quantitative analysis of MR and GR intensity using immunohistochemistry. The
intensity of MR- and GR-ir decreased in the 1 day SPS, and remained virtually unchanged in the 7 days, 14 day SPS in comparison with control group.
MR- (arrow) and GR-ir (arrow head) showed more cytoplasmic distribution in the amygdala of the 7 days and 14 days SPS. *P < 0.05 vs. the control
group.
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covered at 14 days, compared to the control group
(Figure 4).
Ratio of MR/GR in the amygdala
We compared the ratio of MR/GR in the amygdala at in-
tensity of immunoreactivity, protein and mRNA expres-
sion among the control group, 1, 7, and 14 days after
SPS. The ratio of MR/GR at 3 levels showed no signifi-
cant change at 1, 7, and 14 days after SPS in comparison
with the control group (Figure 5).
Discussion
The amygdala plays an important role in fear learning and
fear expression [21]. MRI studies reveal different results
on the volume of the amygdala in patients with PTSD:
smaller and unchanged amygdala volumes in patients with
PTSD [22,23]. In vivo proton magnetic resonance spec-
troscopy (1H-MRS) revealed the high NAA/Cr and Cho/
Cr ratios, which reflect a hyperresponsive amygdala
[10,11]. Increased anxiety-like behavior may also be an im-
portant symptom cluster in patients with PTSD. Our
study found that SPS induced distinct, enhanced fear be-
cause SPS decreased the number of entries into the open
arms in the EPM test, and locomotor activity within the
inner parts of the field in the OF test. These results are
consistent with previous studies [24,25]. Our TEM obser-
vation also found that SPS induced abnormal morpho-
logical changes in the cells of the amygdala: swelling
mitochondria, vacuolation and loss of crest in the
mitochondria, existence of chromatin condensation, nu-
cleus fragmentation and nucleolus disappearance, which
reflected damage of the amygdala neurons after SPS
stimulating.
It is known that MR maintains the basal activity of the
HPA axis, so MR plays a lesser role in regulating the
HPA axis during stress [3,26]. The hippocampal MR inTable 3 The percentage of cells expressing MR- or GR-ir
in the amygdala
MR-ir cells with GR-ir (%) GR-ir cells with MR-ir (%)
Control 93.5 ± 2.3% 92.8 ± 3.4%
SPS-1 day 34.3 ± 2.4% 76.5 ± 4.1%
SPS-7 day 38.7 ± 2.9% 85.2 ± 3.2%
SPS-14 days 91.4 ± 2.45% 69.3 ± 2.7%contrast has neuron protection function [26]. Down-
regulation of hippocampal MR in PTSD is associated
with hippocampal tissue loss [19]. Except for the hippo-
campus, our previous studies using SPS rats examined
neuronal loss in the amygdala [12,24]. We speculated
that low expression levels of MR in the amygdala pro-
moted the loss of neurons, leading to a dysfunctional
amygdala in PTSD. Meanwhile, decreased MR function
is implicated in increased fear-related behaviors in ani-
mals [27]. So a decrease in amygdala MR in PTSD could
be associated with fear-related clinical phenomena, in-
cluding startle-response, hyper-vigilance, and increased
anxiety. On the other hand, decreased expression levels
of amygdala GR in the present study was observed, but
the degree of expression change in GR is less than that
of MR. The excitatory effects of the amygdala on the
HPA axis responses are mediated by hypothalamic
serotonin [15]. Our pervious study examined activity of
hypothalamic 5-HT1A receptors in the alterations of GR
in the hippocampus, and CRF in the hypothalamus of
SPS rats [25]. GR signaling in the amygdala suppresses
excitatory transmission to the HPA axis [28]. So we
speculate that decreased amygdala GR may be involved
in hyperactivity of the HPA axis in PTSD. The present
study found that SPS causes a decrease in the expression
of MR and GR in the amygdala of SPS rats at the level
of protein and mRNA. But other studies using Sprague–
Dawley rats show that amygdala GR did not change after
SPS [29,30]. The different results may depend on the
strain of rat and differences in GR and MR expression.
In general, decreased MR and GR promote neuronal
death in the amygdala, causing changes in amygdala
volume and enhanced fear in PTSD.
The present study revealed that MR-ir shows a greater
distribution in the cytoplasm compared to GR-ir, and SPS
caused more cytoplasmic distribution of both receptors. It
is known that MR and GR are hormone-dependent tran-
scription factors, translocating to the nucleus after binding
to the hormone ligand, and then regulating neuronal ex-
citability, growth and cell survival and neuroendocrine
function [31]. We believe that an increase in cytoplasmic
distribution of MR and GR after 7 days SPS indicates that
cytoplasmic MR and GR could not regulate neuronal
activity, because low glucocorticoids or changes in the
structures of MR and GR protein induced by low gluco-
corticoids [32]. This may explain why, after 7 days SPS,
Figure 3 Western blot of MR and GR in the amygdala of SPS rats. Figure 3 shows that MR and GR protein expression in the amygdala and
quantitative analysis based on western blot results. A significant decrease in MR and GR protein expression in the amygdala was observed at
1 day, 7 days and 14 days after SPS exposure in comparison with the control group. But MR and GR protein showed an increased tendency at 7
and 14 days in comparison with 1 day after SPS (no significant difference). In the control group, MR protein was significantly higher than GR
protein. *P < 0.05 vs. the control group; #P < 0.05 vs. MR.
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not correct dysfunctions of the amygdala. On the other
hand, the present study clearly showed that MR- and
GR-ir was colocalized in the amygdala. Colocalization of
MR- and GR-ir in the hippocampus has been reported
[31,33]. Studies from in vitro and in vivo experiments sug-
gest that MR and GR form not only homodimers but also
heterodimers [33,34]. Colocalized cells could be explained
by the existence of MR and GR heterodimer. Receptor
heterodimers may contribute to the biphasic excitation of
neurons to corticosterone [3,26]. Decreased numbers of
MR/GR colocalized cells after SPS suggests a decrease
in neuronal activation in response to corticosterone in
PTSD. In sum, the decrease in the numbers of colocalized
cells as well as increased cytoplasmic distribution of both
receptors in the amygdala of SPS rats provide evidence for
decreased function of MR and GR in the amygdala of SPS
rats.
The balance of MR and GR expression in the brain
plays a key role in the regulation of neuronal excitability,
stress responses and behavior [3,26]. The normal expres-
sion ratio of these receptors is considered a protective
factor against responses to stress, and promotes health,
homeostasis, and adaptation [3]. A change in balance ofboth receptors alters the ability to maintain homeostasis,
which in turn alters neuronal excitability, stress respon-
siveness, and behavioral adaptation to a condition of en-
hanced vulnerability to disease [26]. An imbalance in the
MR:GR ratio in the hippocampus of SPS rats has been
described in our previous study [19]. In contrast to the
hippocampus, we did not detect a significant difference
in the MR:GR ratio in the amygdala of SPS rats.
However we cannot rule out the possibility of functional
actions influencing neurons in the PTSD amygdala
through mechanisms mediated by the MR:GR ratio. The
MR:GR ratio in the amygdala following SPS was quite
different from that in the hippocampus. Differential ef-
fects of stress on the hippocampus and the amygdala
have been described [35]. One possible explanation is
that the MR:GR ratio and regulation might vary by brain
region, e.g., in low birth weight related depression, there
is a change in the MR:GR ratio in the hippocampus but
not in the amygdala [31,36]. Sarabdjitsingh has also re-
ported that stress and corticosterone change synaptic
potentiation in the amygdala in a manner opposite to
that seen in the hippocampus [37]. These studies have
delineated region-specific effects of corticosterone in the
neuronal physiology between the hippocampus and the
Figure 4 RT-PCR of MR and GR in the amygdala of the SPS rats. MR and GR mRNA expression and results from quantitative analysis. MR and
GR mRNA level in the amygdala of SPS 1 day and 7 days were lower than that in the amygdala of control rats. But no significant difference was
found between control group and SPS 14 days group. *P < 0.05 vs. the control group.
Figure 5 MR:GR ratio in the amygdala cells. MR:GR ratio of protein and mRNA expression shows no significant change between groups.
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of MR/GR in the amygdala may be more unique or
flexible [33,38,39].
Conclusion
Our study examined that SPS induced enhanced fear/
anxious. TEM revealed abnormal morphology of the amy-
gdala neurons. The expression of MR- and GR-ir intensity,
mRNA and protein within the amygdala decreased after
SPS at 1 day, and then gradually recovered by 14 days,
although the degree of decrease and recovery were dif-
ferent amongst techniques. But the MR:GR ratio did not
show significant change. Dual fluorescence histochemistry
showed increased cytoplasmic distribution of MR- and
GR-ir in the SPS group compared to the control group.
These data indicate that activation of MR and GR in the
amygdala are involved in the mechanisms of fear in PTSD.
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